raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:464453

Acquired methemoglobinemia

Synonyms: Drug-induced methemoglobinemia

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
All ages
Status
active

A rare hematologic disease characterized by increased levels of methemoglobin in the blood due to exposure to oxidizing agents like nitrates or nitrites, a variety of medications (most commonly local anesthetics), or aniline dyes, among others. Clinical manifestations include cyanosis, dizziness, headache, dyspnea, confusion, and coma. The severity of symptoms ranges from mild to life-threatening, depending on the percentage of methemoglobin.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAcquired methemoglobinemiaDrug-induced methemoglobinemia
frMéthémoglobinémie acquiseMéthémoglobinémie induite par les médicaments
deMethämoglobinämie, erworbeneMethämoglobinämie, Medikamenten-induzierte
esMetahemoglobinemia adquiridaMetahemoglobinemia inducida por fármacos
itMetaemoglobinemia acquisita
nlVerworven methemoglobinemieMedicatiegeïnduceerde methemoglobinemie
ptMetahemoglobina adquirida
plMethemoglobinemia nabytaMethemoglobinemia indukowana lekami
csZískaná methemoglobinémieDrug-induced methemoglobinemia · Methemoglobinémie vyvolaná léky
ukНабута метгемоглобінеміяМедикаментозна метгемоглобінемія
zh获得性高铁血红蛋白血症药物诱导的高铁血红蛋白血症
trEdinsel methemoglobinemiİlaç-ilişkili methemoglobinemi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10D74.8NTBTinclusionvalidated
ICD-113A93Especificvalidated
MONDO0018740Evalidated
UMLSC0271905Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families242 casesWorldwideCase(s)Validated15342970[PMID]_19224791[PMID]
Point prevalenceUnknown—WorldwideClass onlyValidatedORPHANET_15342970[PMID]_19224791[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

21 annotations · validated 2019-05-13
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0012119Methemoglobinemia
Frequent (79-30%)
HP:0001941Acidosis
HP:0000739Anxiety
HP:0001289Confusion
HP:0000961Cyanosis
HP:0002094Dyspnea
HP:0012378Fatigue
HP:0002315Headache
HP:0012418Hypoxemia
HP:0001962Palpitations
HP:0002321Vertigo
HP:0002013Vomiting
Occasional (29-5%)
HP:0002027Abdominal pain
HP:0011675Arrhythmia
HP:0001259Coma
HP:0002329Drowsiness
HP:0007185Loss of consciousness
HP:0001279Syncope
HP:0001649Tachycardia
Very rare (<4-1%)
HP:0002098Respiratory distress
HP:0001250Seizure

Run the differential on the 1 obligate / very frequent terms

Annotation source: 25637615[PMID]_27412886[PMID]_28667718[PMID]

7

Sources for this card